| # | Drug | Count |
|---|---|---|
| 0 | BACLOFEN | 206 |
| 1 | CABERGOLINE | 108 |
| 2 | BACLOFEN INJECTION | 100 |
| 3 | ADALIMUMAB | 99 |
| 4 | NUSINERSEN | 79 |
| 5 | GABAPENTIN | 77 |
| 6 | ACETAMINOPHEN | 71 |
| 7 | METHOTREXATE SODIUM | 49 |
| 8 | HYDROMORPHONE HYDROCHLORIDE | 45 |
| 9 | METHOTREXATE | 44 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | THROMBIN HUMAN AND FIBRINOGEN | 15 | 0.0446 |
| 1 | BACLOFEN INJECTION | 100 | 0.0321 |
| 2 | CABERGOLINE | 108 | 0.0219 |
| 3 | SODIUM PHOSPHATE, DIBASIC AND SODIUM PHOSPHATE, MONOBASIC | 1 | 0.0122 |
| 4 | ZICONOTIDE ACETATE | 28 | 0.0115 |
| 5 | PENTOBARBITAL SODIUM | 1 | 0.0108 |
| 6 | NUSINERSEN | 79 | 0.0100 |
| 7 | CERLIPONASE ALFA | 4 | 0.0075 |
| 8 | IMIPRAMINE PAMOATE | 1 | 0.0061 |
| 9 | CARMUSTINE | 22 | 0.0047 |
| # | Drug class | Count |
|---|---|---|
| 0 | gamma-Aminobutyric Acid-ergic Agonist [EPC] | 289 |
| 1 | Corticosteroid [EPC] | 163 |
| 2 | Ergot Derivative [EPC] | 108 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 107 |
| 4 | Benzodiazepine [EPC] | 103 |
| 5 | Opioid Agonist [EPC] | 80 |
| 6 | Antisense Oligonucleotide [EPC] | 79 |
| 7 | Survival Motor Neuron-2-directed RNA Interaction [EPC] | 79 |
| 8 | Alkylating Drug [EPC] | 57 |
| 9 | Proton Pump Inhibitor [EPC] | 51 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Ergot Derivative [EPC] | 108 | 0.0219 |
| 1 | Human Blood Coagulation Factor [EPC] | 15 | 0.0182 |
| 2 | Antisense Oligonucleotide [EPC] | 79 | 0.0066 |
| 3 | gamma-Aminobutyric Acid-ergic Agonist [EPC] | 289 | 0.0032 |
| 4 | Carboxypeptidase [EPC] | 1 | 0.0028 |
| 5 | Diagnostic Dye [EPC] | 1 | 0.0015 |
| 6 | Serotonin-4 Receptor Agonist [EPC] | 1 | 0.0015 |
| 7 | Benzodiazepine Antagonist [EPC] | 1 | 0.0011 |
| 8 | Dopamine and Norepinephrine Reuptake Inhibitor [EPC] | 4 | 0.0010 |
| 9 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 7 | 0.0010 |